Valrubicin - Valderm

Drug Profile

Valrubicin - Valderm

Alternative Names: Topical valrubicin; Valrubicin cream

Latest Information Update: 26 Aug 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Valderm
  • Class Anthracyclines; Antineoplastics; Cytostatics; Small molecules
  • Mechanism of Action DNA intercalators; DNA repair enzyme inhibitors; Type II bacterial DNA topoisomerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Plaque psoriasis

Most Recent Events

  • 26 Aug 2015 Discontinued - Phase-II for Plaque psoriasis in Germany (Topical)
  • 17 Sep 2011 Valderm completes its phase IIa trial for Plaque psoriasis in Germany
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top